Cineplex Stock May Be a Brilliant Bet Going Into Summer

Cineplex (TSX:CGX) stock may be on the cusp of a summertime boom. But with resurgence risks still in full swing, should you be a buyer?

| More on:

Cineplex (TSX:CGX) stock has been under pressure again, with the name recently dipping just over 20% from its six-month high. With the ongoing third wave of COVID-19, the Canadian movie theatre giant is due for another round of brutal numbers.

On the other side of this horrific spring surge is a summer season that could have the potential to be far brighter than last year’s. Every day that goes by, more Canadians are getting vaccinated, bringing us ever so closer to herd immunity. As the insidious coronavirus looks to abate going into the summer season, the nation will have a chance to accelerate its vaccination efforts and gain the upper hand over new variants.

Be optimistic while others are pessimistic

It’s been a dark spring, with COVID-19 restrictions still in place for many provinces. Despite this, people are as optimistic as ever amid the ongoing vaccine rollout. Summer is just around the corner, and normalcy is within grasp. While COVID-19 probably won’t be eradicated this year or even next year, I think that fully vaccinated Canadians who’ve received both doses will feel far more confident about heading back to establishments like movie theatres, arcades, and all the sort once the government removes restrictions.

Such an environment could fuel an epic boom for Cineplex. The company may finally get a chance to recover after nearly a year and a half of depressed revenues at the hands of restrictions. For those willing to put up with the volatility and give Cineplex a free pass for its meagre first-quarter results, I think there’s a lot to gain, as we make major strides to the light at the end of the tunnel.

Cineplex: The road ahead looks bright

The company is fresh off an 85% year-over-year plunge in quarterly earnings. Net losses were also clocked in at just shy of $90 million. It was a brutal quarter, but should it have been a surprise? Probably not.

Fellow Fool contributor Chris MacDonald seems to think Cineplex is still a top reopening play after its latest post-earnings pullback, and I think he’s right on the money. MacDonald highlights that high-risk establishments like theatres are poised to revamp their air-intake systems to make consumers feel safer and more comfortable:

“Movie theatre operators have been reiterating that their operations are much safer when compared to retail stores and restaurants. They believe that since the theatres are spacious, social distancing won’t be a problem,” MacDonald wrote. “Furthermore, businesses are looking to alter their air-intake system to substantially increase airflow. Such upgrades could go a long way to providing a road map for regulators to open up movie theatres.”

I think such initiatives will be vital to Cineplex’s recovery. Even people who’ve been vaccinated with both doses and the latest booster will still get anxious if they hear someone coughing down the aisle.

Foolish takeaway on Cineplex stock

With a growing backlog of theatrical releases, pent-up demand for social activities, and restrictions likely to be lifted, I think Cineplex stock is a must-own for venturesome Canadian investors who are no strangers to extreme volatility.

An autumn resurgence could stop Cineplex’s recovery in its tracks. That’s the biggest risk investors need to come to terms with. Regardless, I’m still a fan of the risk/reward scenario going into the summer and would look to scoop up shares after its post-earnings flop.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool recommends CINEPLEX INC.

More on Dividend Stocks

Dividend Stocks

Top Canadian Stocks to Buy Right Now With $1,000

Investing in stocks is not about timing but consistency. If you have $1,000 to invest, these stocks offer an attractive…

Read more »

cloud computing
Dividend Stocks

Is Manulife Stock a Buy for its 3.5% Dividend Yield?

Manulife stock has been a long-time dividend winner, but the average has come down over the last few years. So…

Read more »

Person holds banknotes of Canadian dollars
Dividend Stocks

This 7.5% Dividend Stock Pays Cash Every Single Month

Monthly dividend income can be a saviour, but especially when it provides passive income like this!

Read more »

jar with coins and plant
Dividend Stocks

2 High-Yield Dividend Stocks You Can Buy and Hold for a Decade

These TSX stocks still offer attractive dividend yields.

Read more »

concept of real estate evaluation
Dividend Stocks

Invest $23,253 in This Stock for $110 in Monthly Passive Income

Dividend investors don’t need substantial capital to earn monthly passive income streams from an established dividend grower.

Read more »

Dividend Stocks

3 Mid-Cap Canadian Stocks That Offer Reliable Dividends

While blue-chip, large-cap stocks are the preferred choice for most conservative dividend investors, there are some solid picks in the…

Read more »

The letters AI glowing on a circuit board processor.
Dividend Stocks

Is OpenText Stock a Buy for Its 3.6% Dividend Yield?

OpenText stock has dropped 20% in the last year, yet now the company looks incredibly valuable, especially with a 3.6%…

Read more »

calculate and analyze stock
Dividend Stocks

How to Use Your TFSA to Earn $6,905.79 Per Year in Tax-Free Income

Put together a TFSA and this TSX stock, and you could create massive passive income from returns and dividends.

Read more »